2
Clinical Trials associated with Neoantigen Personalized mRNA Vaccine(Akeso) / Not yet recruitingPhase 1 An Exploratory Study to Evaluate Safety and Efficacy of the Neoantigen Personalized mRNA Vaccine AK154 Monotherapy or in Combination With AK104 or AK112,and the Sequential mFOLFIRINOX Regimen as Adjuvant Therapy in Surgically Resectable Pancreatic Ductal Adenocarcinoma
To explore safety and efficacy of neoantigen personalized mRNA vaccines AK154 monotherapy or in combination with AK104/AK112 and sequential mFOLFIRINOX regime in Resected PDAC
/ RecruitingEarly Phase 1IIT Clinical research on personalized mRNA neoantigen vaccine (AFN18) for the treatment of solid tumors
100 Clinical Results associated with Neoantigen Personalized mRNA Vaccine(Akeso)
100 Translational Medicine associated with Neoantigen Personalized mRNA Vaccine(Akeso)
100 Patents (Medical) associated with Neoantigen Personalized mRNA Vaccine(Akeso)
100 Deals associated with Neoantigen Personalized mRNA Vaccine(Akeso)